Genocea to Present at the 20th Annual Needham Virtual Healthcare Conference
CAMBRIDGE, Mass., April 06, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, President and Chief Executive Officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13th at 2:15 P.M. ET.
A live webcast of the presentation will be available "Events and Presentations" tab of the investor relations section of the Genocea website at http:/ir.genocea.com. Following the conclusion of the conference, the presentation will remain archived on the Genocea website for approximately 90 days.
About Genocea Biosciences, Inc.
Exploring Post-Pandemic Best Practice
Boosting your UC and Conferencing Revenue
Can Zero Trust Quiet the Noise Around Cyber Security?